Search research articles
Contact Us
Filters
Showing results (31-40 of 57) with videos related to
Page
of 6
Sort By:
Scandinavian Journal of Gastroenterology
|
March 4, 2005
Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years
M Hage, P D Siersema, H van Dekken, et al.
The American Journal of Gastroenterology
|
October 16, 1999
Gastroesophageal reflux and Barrett's esophagus in adults born with esophageal atresia
E Krug, J H Bergmeijer, J Dees, et al.
Endoscopy
|
November 1, 1990
Malignant common bile duct obstruction: factors influencing the success rate of endoscopic drainage
J Boender, G A Nix, H E Schütte, et al.
Scandinavian Journal of Gastroenterology
|
October 1, 1990
Five-year cimetidine maintenance trial for peptic ulcer disease. A clinical and endocrinologic approach
G N Tytgat, W Hameeteman, C J Mulder, et al.
European Radiology
|
April 16, 1998
Giant esophageal polyp: a clinical and radiological entity with variable histology
A Z Ginai, B C Halfhide, J Dees, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1981
A Vibrio cholerae infection in a transient teamster
F F Holmes, B Wells, D J Dees, et al.
The Netherlands Journal of Medicine
|
August 1, 1995
Early detection and treatment of oesophageal and gastric cancer. The Rotterdam Oesophageal Tumour Study Group
P D Siersema, J Dees, H W Tilanus, et al.
Digestion
|
January 1, 1982
Factors determining the occurrence of serum agglutinins to eubacterium and peptostreptococcus species in patients with Crohn's disease and ulcerative colitis
J P van de Merwe, G J Mol, F Wensinck, et al.
Archives of Internal Medicine
|
February 1, 1985
Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms
P N Lelie, H W Reesink, S T de Jong-van Manen, et al.
American Journal of Epidemiology
|
November 1, 1984
Immunogenicity and safety of a plasma-derived heat-inactivated hepatitis B vaccine (CLB). Studies in volunteers at a low risk of infection with hepatitis B virus
P N Lelie, H W Reesink, S T de Jong-van Manen, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 57) with videos related to
Sort By:
Page
of 6
Scandinavian Journal of Gastroenterology
|
March 4, 2005
Oesophageal cancer incidence and mortality in patients with long-segment Barrett's oesophagus after a mean follow-up of 12.7 years
M Hage, P D Siersema, H van Dekken, et al.
The American Journal of Gastroenterology
|
October 16, 1999
Gastroesophageal reflux and Barrett's esophagus in adults born with esophageal atresia
E Krug, J H Bergmeijer, J Dees, et al.
Endoscopy
|
November 1, 1990
Malignant common bile duct obstruction: factors influencing the success rate of endoscopic drainage
J Boender, G A Nix, H E Schütte, et al.
Scandinavian Journal of Gastroenterology
|
October 1, 1990
Five-year cimetidine maintenance trial for peptic ulcer disease. A clinical and endocrinologic approach
G N Tytgat, W Hameeteman, C J Mulder, et al.
European Radiology
|
April 16, 1998
Giant esophageal polyp: a clinical and radiological entity with variable histology
A Z Ginai, B C Halfhide, J Dees, et al.
The American Journal of Tropical Medicine and Hygiene
|
November 1, 1981
A Vibrio cholerae infection in a transient teamster
F F Holmes, B Wells, D J Dees, et al.
The Netherlands Journal of Medicine
|
August 1, 1995
Early detection and treatment of oesophageal and gastric cancer. The Rotterdam Oesophageal Tumour Study Group
P D Siersema, J Dees, H W Tilanus, et al.
Digestion
|
January 1, 1982
Factors determining the occurrence of serum agglutinins to eubacterium and peptostreptococcus species in patients with Crohn's disease and ulcerative colitis
J P van de Merwe, G J Mol, F Wensinck, et al.
Archives of Internal Medicine
|
February 1, 1985
Immune response to a heat-inactivated hepatitis B vaccine in patients undergoing hemodialysis. Enhancement of the response by increasing the dose of hepatitis B surface antigen from 3 to 27 micrograms
P N Lelie, H W Reesink, S T de Jong-van Manen, et al.
American Journal of Epidemiology
|
November 1, 1984
Immunogenicity and safety of a plasma-derived heat-inactivated hepatitis B vaccine (CLB). Studies in volunteers at a low risk of infection with hepatitis B virus
P N Lelie, H W Reesink, S T de Jong-van Manen, et al.
Page
of 6